Impact BioMedical, Inc. - IBO Company Long-Term Liabilities

The available price action for Impact BioMedical Inc (IBO) reflects the dynamics of a company integrating ESG standards into its project management for combating viruses and bacteria. However, the lack of recurring revenue and a dependence on investments create significant risks, with long-term debt amounting to 0.00. The business relies on a diversified patent portfolio, including sugar substitutes, monetizing licenses across various medical segments.

IBO impactbiomedinc.com Company Long-Term Liabilities (09/17/2024 - 10/28/2026)

Metric breakdowns and analytics for Impact BioMedical (IBO)

- price and consensus price forecast:
Price Performance Chart impactbiomedinc.com|IBO - Price Target Chart
- market capitalization data:
Market Valuation Impact BioMedical|IBO - Enterprise Value
- book capitalization data:
Book Value per Share Impact BioMedical|IBO - Company Net Assets|Market Value to Book Value impactbiomedinc.com|IBO - Aggregate Company Assets
- debt and liquidity data:
Debt to Capital Impact BioMedical Inc|IBO - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Impact BioMedical, Inc.|IBO - Company Aggregate Debts|Debt to Net Assets Ratio Impact BioMedical|IBO - Company Long-Term Debts|Short-Term Debt Impact BioMedical
Comprehensive company analysis:IBO (impactbiomedinc.com)

This indicator mathematically reflects the ability of cash flows to service long-term loans. The metric measures total liabilities with a maturity of more than one year, determining the level of financial leverage. For Impact BioMedical Inc (IBO), such loans often fund a highly qualified research staff and the development of innovations. By analyzing the size of the issuer's long-term liabilities, an investor assesses the business model's resilience to changes in interest rates.

Direct competitors

haleon.com - Company Long-Term Loans and Borrowings|KVUE: Company Long-Term Debt|VRNA - Company Long-Term Liabilities|MENS: Company Long-Term Debts|Company Long-Term Debts Ligand Corp|AMRX - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings PRGO|Alvotech SA - Company Long-Term Debt|Long-Term Debt Liquidia Corp LQDA|Company Long-Term Liabilities Galapagos Genomics (GLPG)|Amount of Long-Term Liabilities ANI Pharmaceuticals Corp ANIP|Company Long-Term Debts MannKind Corporation (MNKD)|AMPH - Company Long-Term Loans and Borrowings|Company Long-Term Debts PCRX|SPRY (ARS Pharmaceuticals Inc) - Long-Term Debt|TBPH - Company Long-Term Debt|Company Long-Term Loans and Borrowings Aquestive Corp|SCPH (scPharmaceuticals Inc.) - Company Long-Term Debts|Long-Term Debt Volume TECX (tectonictx.com)|Tonix Pharmaceuticals Holding Corp. - Company Long-Term Debt|SXT Pharmaceuticals - Company Long-Term Liabilities|Company Long-Term Debt Eupraxia Pharma|BHST - Long-Term Liabilities|EXOZ: Company Long-Term Debts|Oramed Pharmaceuticals Inc. (ORMP) - Company Long-Term Debts|Company Long-Term Debts ENTX|Company Long-Term Liabilities MindWalk Holdings, Inc. (HYFT)|Company Long-Term Liabilities ABVC BioPharma Inc|Amount of Long-Term Liabilities Cumberland Corp CPIX|Company Long-Term Liabilities Quantum BioPharma Ltd|Company Long-Term Loans and Borrowings fibrogen.com FGEN|TELO - Company Long-Term Debts|RANI - Company Long-Term Debt|synergychc.com - Company Long-Term Debts|RLYB (Rallybio) - Long-Term Debt Volume|Company Long-Term Debt LEXX (Lexaria Bioscience Corp)|Long-Term Debt PULM|Company Long-Term Debt PTHL (Pheton Holdings Ltd)|Company Long-Term Liabilities aptorumgroup.com (APM)|LYRA: Company Long-Term Debts|Long-Term Debt TNF Pharmaceuticals Inc. TNFA|cbdMD Corp (YCBD) - Company Long-Term Debts|PRFX - Company Long-Term Indebtedness|altamiratherapeutics.com - Company Long-Term Debts|Lipella Pharmaceuticals Inc (LIPO) - Long-Term Debt Volume|Company Long-Term Debts OPTN|Company Long-Term Liabilities Pieris Pharma|Company Long-Term Debts PROC|Company Long-Term Debts PTPI (petrospharma.com)|Company Long-Term Debt Qilian International Holding QLI|SLRN - Company Long-Term Debt|Company Long-Term Liabilities TFF Pharma (TFFP)